Zeon Invests in Knowledge Palette to Develop AI Drug Discovery Technology

Zeon has recently invested in Knowledge Palette, a company which develops AI drug discovery technology using single-cell transcriptome analysis. Knowledge Palette applies the world’s most accurate single-cell transcriptome analysis technology (Quartz-Seq2) to acquire large-scale data on the state of disease-causing cells. By using this information and AI technology to elucidate the causes of disease outbreaks, the company aims to efficiently…

Please subscribe to read the full story.

Log In

, ,